Disclaimers & Citations

Effective Date:

Disclaimers

  • BLOCH Quantum Imaging Solutions, Inc. dba BeSound (“BeSound”) provides imaging equipment and administrative and management services only; all medical and clinical services are rendered by Agape Medical Group PC (the “PC”), the PC’s contracted professional services partners or other provider groups receiving services from BeSound.
  • BeSound offers breast imaging using advanced ultrasound and near-infrared light technology, where clinically indicated, performed by trained sonographers and read by Board-certified radiologists.  BeSound does not currently offer mammograms and is not intended as a replacement for mammograms. The American Cancer Society (https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html)* recommends that women with an average risk for breast cancer begin receiving regular mammograms at the age of 40. Women who are at a higher risk for breast cancer are recommended to receive a mammogram along with a breast MRI typically starting at age 30.
  • BeSound provides supplemental screening for adult women with dense breasts for whom screening mammography findings are normal or benign and who have not had previous clinical breast intervention. BeSound also offers diagnostic breast ultrasound for women with palpable and non-palpable breast abnormalities in adult women who are referred for a diagnostic imaging breast work‐up, following clinical presentation or either screening or diagnostic mammography or other imaging examinations.
  • BLOCH Quantum Imaging Solutions, Inc. d/b/a BeSound is a technology platform that connects individuals with independent partner medical groups that provide breast imaging services. These services may include the use of advanced ultrasound and near-infrared light technology, where clinically appropriate. Imaging exams are performed by trained sonographers and interpreted by board-certified radiologists engaged by the partner medical groups. BeSound does not provide medical care, make clinical decisions, or employ healthcare professionals. All medical services are delivered solely by independently owned and operated partner medical groups.

    The services offered through BeSound’s platform are intended to support supplemental breast imaging and are not a replacement for mammography. The American Cancer Society recommends that women at average risk begin regular mammograms at age 40. Women at higher risk may require earlier screening and additional imaging, such as breast MRI, starting at age 30. Partner medical groups may offer supplemental screening for adult women with dense breasts who have had normal or benign mammography results and no prior clinical breast interventions. Diagnostic breast ultrasound may also be available for individuals referred for further imaging of palpable or non-palpable abnormalities following clinical evaluation or imaging. All clinical services accessible via the BeSound platform are provided exclusively by independent partner medical groups. BeSound is not a healthcare provider.
1*. When compared to the standard of care which is the mammogram

Citations (*)

01. 28 days is the amount of time it can take from initial screening to Breast Cancer Diagnosis, and still longer before treatment begins.
https://www.ncbi.nlm.nih.gov/…articles/PMC5482732/
02. 43% (rounded to 1 in 2) women between the ages of 40 to 74 have dense breasts. Dense Breasts are a risk factor for breast cancer.
https://pubmed.ncbi.nlm.nih.gov/25217577/
03. 40% of cancers in women with dense breasts are missed by mammography.
https://pubmed.ncbi.nlm.nih.gov/32903054/
04. 99% of breast cancers are survivable with early detection.
https://womenshealth.gov/blog/99-percent-survival-rate-breast-cancer-caught-early
05. BeSound’s partner’s technology has demonstrated in real world studies to reduce false positive breast biopsies by up to 75%.
https://senomedical.com/assets/pdfs/Seno-Medical-Imagio-ebook.pdf